C3 Hypocomplementemia Predicts the Progression of CKD towards End-Stage Kidney Disease in IgA Nephropathy, Irrespective of Histological Evidence of Thrombotic Microangiopathy
- PMID: 38731122
- PMCID: PMC11084933
- DOI: 10.3390/jcm13092594
C3 Hypocomplementemia Predicts the Progression of CKD towards End-Stage Kidney Disease in IgA Nephropathy, Irrespective of Histological Evidence of Thrombotic Microangiopathy
Abstract
Background: IgA nephropathy (IgAN) is the most common primary glomerulonephritis worldwide. IgAN causes end-stage kidney disease (ESKD) in 30-40% of all cases. The activation of the complement system by pathological circulating IgAs, which is often associated with low serum C3 levels (LowC3), seems to play a crucial role. Previous studies have shown an association between histological evidence of TMA, which is the result of alternative complement activation, and poor outcomes. However, it is not known to what extent the decrease in serum C3 levels reflects ongoing TMA injury. Our study aimed at assessing the association between LowC3 and ESKD and whether this association reflects ongoing TMA. Methods: We enrolled all patients with biopsy-proven IgAN and followed-up patients until their last visit, ESKD, or death. Results: Of the 56 patients included in the study, 12 (21%) presented low serum C3 (LowC3) at the time of renal biopsy. TMA was significantly more frequent in the LowC3 group [7/12 (58%) vs. 9/44 (20%), p = 0.02]. After adjusting for potential confounders, LowC3 was strongly associated with an increased hazard of ESKD (hazard ratio [HR]: 5.84 [95%CI: 1.69, 20.15; p = 0.005). The association was not affected by adjusting for TMA. The estimated overall proportion of the relation between C3 and ESKD mediated by TMA was low and not statistically significant. Conclusions: Our study provides evidence that C3 hypocomplementemia is associated with an increased risk of ESKD through mechanisms that are largely independent from TMA.
Keywords: IgA nephropathy; complement; end-stage kidney disease; thrombotic microangiopathy.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Persistent Isolated C3 Hypocomplementemia as a Strong Predictor of End-Stage Kidney Disease in Lupus Nephritis.Kidney Int Rep. 2022 Sep 17;7(12):2647-2656. doi: 10.1016/j.ekir.2022.09.012. eCollection 2022 Dec. Kidney Int Rep. 2022. PMID: 36506236 Free PMC article.
-
Case Report: A Rare Truncating Variant of the CFHR5 Gene in IgA Nephropathy.Front Genet. 2021 May 20;12:529236. doi: 10.3389/fgene.2021.529236. eCollection 2021. Front Genet. 2021. PMID: 34220921 Free PMC article.
-
Clinicopathological Characteristics and Impacts on Clinical Outcomes of Thrombotic Microangiopathy Lesions in Patients with Immunoglobulin A Nephropathy in Thailand.Am J Nephrol. 2023;54(7-8):308-318. doi: 10.1159/000531693. Epub 2023 Jul 10. Am J Nephrol. 2023. PMID: 37429271
-
IgA nephropathy and atypical hemolytic uremic syndrome: a case series and a literature review.J Nephrol. 2022 May;35(4):1091-1100. doi: 10.1007/s40620-021-01189-6. Epub 2021 Nov 10. J Nephrol. 2022. PMID: 34757577 Review.
-
Glomerular endothelial activation, C4d deposits and microangiopathy in immunoglobulin A nephropathy.Nephrol Dial Transplant. 2021 Mar 29;36(4):581-586. doi: 10.1093/ndt/gfz241. Nephrol Dial Transplant. 2021. PMID: 31755918 Review.
References
-
- Berger J., Hinglais N. Intercapillary deposits of IgA-IgG. J. Urol. Nephrol. 1968;74:694–695. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous